Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,081 JPY | -0.67% | -0.43% | -4.15% |
2023 | HABA Laboratories,Inc. Reports Earnings Results for the Full Year Ended March 31, 2023 | CI |
2021 | HABA Laboratories,Inc.(JASDAQ:4925) dropped from S&P Global BMI Index | CI |
Sales 2022 | 12.91B 82M | Sales 2023 | 12.04B 76.48M | Capitalization | 8.81B 55.98M |
---|---|---|---|---|---|
Net income 2022 | -269M -1.71M | Net income 2023 | -707M -4.49M | EV / Sales 2022 | 0.39 x |
Net cash position 2022 | 3.09B 19.66M | Net cash position 2023 | 2.78B 17.69M | EV / Sales 2023 | 0.5 x |
P/E ratio 2022 |
-30.4
x | P/E ratio 2023 |
-12.5
x | Employees | 654 |
Yield 2022 |
1.85% | Yield 2023 |
1.72% | Free-Float | 56.05% |
1 day | -0.67% | ||
1 week | -0.43% | ||
1 month | +3.38% | ||
3 months | +0.05% | ||
6 months | -8.00% | ||
Current year | -4.15% |
Managers | Title | Age | Since |
---|---|---|---|
Issei Miyazaki
CEO | Chief Executive Officer | 61 | 13-09-30 |
Noriko Koyanagi
CHM | Chairman | 78 | 15-05-31 |
Chief Tech/Sci/R&D Officer | 59 | 20-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tsunekazu Umeda
BRD | Director/Board Member | 78 | 00-05-31 |
Noriko Koyanagi
CHM | Chairman | 78 | 15-05-31 |
Issei Miyazaki
CEO | Chief Executive Officer | 61 | 13-09-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 2,081 | -0.67% | 400 |
24-05-30 | 2,095 | -0.52% | 5,500 |
24-05-29 | 2,106 | +0.38% | 4,200 |
24-05-28 | 2,098 | +0.38% | 1,900 |
24-05-27 | 2,090 | -.--% | 1,300 |
Delayed Quote Japan Exchange, May 31, 2024 at 01:03 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-4.15% | 50.05M | |
+0.32% | 262B | |
+18.76% | 20.37B | |
-.--% | 19.29B | |
+16.91% | 12.64B | |
-16.59% | 8.94B | |
+33.93% | 8.62B | |
+9.55% | 5.93B | |
-12.08% | 3.92B | |
-16.83% | 3.84B |
- Stock Market
- Equities
- 4925 Stock